Dose controlled and targetted drug delivery technology for license
| Profil Titel | Dose controlled and targetted drug delivery technology for license | |
Referenz | 11 GB 46P4 3LHU | |
| Herkunftsland | United Kingdom | |
| Kooperationsart | Angebot | |
| Eintrag/Änderung | 2011-06-27 / 2011-09-23 | |
| Status | Dieses Profil ist abgelaufen! Falls Sie denoch Interesse haben, kontaktieren Sie uns. (2012-05-12) |
Kurzfassung
A Scottish company is offering an innovative encapsulation technology for the controlled release of combination products. Patent protected, the product provides controlled and multi-phase release for single or combination prescription and over the counter medicines. Partners are sought in both the pharmaceutical and nutraceutical industries for technical co-operation, joint venture and manufacturing collaboration.
Details
Over recent years, controlled release combination products have become increasingly popular within the pharmaceutical industry. Controlled release combination products present complex challenges to formulators and manufacturers such as physico-chemical and biological compatibility, process scale up and packaging. An ideal solution is the product/delivery system described here by a Scottish company.
The company has 20 years experience with global new product development and life-cycle management programmes.
Based on liquid-fill two piece capsule technology the product is a single oral dosage unit that comprises a capsule in a capsule. Liquid fill hard capsules are a well established and proven method of drug delivery, with many advantages over traditional oral drug formulations such as tablets, powders or pellets in capsules and soft gel capsules.
Patent protected, the product provides controlled and multi-phase release for single or combination prescription and over the counter medicines. The delivery system includes:·
*Two independent compartments in one dosage unit
*Inner capsule contains liquid, semi-solid or powder formulation
*Outer capsule contains liquid or semi-solid formulation
*Drug delivery targeted to two different regions of the GI (Gastrointestinal) tract
*Sustained, pulsed or delayed release profiles
Innovative Aspects:
The product technology is innovative and has patents approved for both EU and for USA. These patents are applicable when the same drug product is used in both the inner and outer capsule.This is unique and a competitive advantage.
General advantages of the product delivery system offered include:
*Controlled & multi-phase release
*Single oral dosage unit
*Novel formulation combinations
*Pilot to commercial manufacture
*Patient convenience & compliance
*Cost effective therapy
*Delivery of incompatible APIs
*Broad therapeutic applications
*Patent protected line extensions
*Reduced time to market
*Brand differentiation
Technologiesektor | - Klinische Forschung, Versuche - Medizinische Forschung - Pharmazeutische Produkte / Medikamente - In vitro Tests, Versuche - Toxikologie |
Anwendungsbereich | - Drug delivery and other equipment - Pharmaceuticals/fine chemicals |
Entwicklungstand | Already on the market |
Patentrechte (IPR) | Patent(s) granted |
Kooperationstyp | - License Agreement - Joint further development - Testing of new applications - Adaptation to specific needs - Joint Venture Agreement Partners from pharmaceutical and nutraceutical academia and/or industry are sought to provide drug candidates being formulated for controlled and multi-phase release for single or combination prescription and OTC (over the counter) medicines. The Scottish company can assist both formulators and manufacturers with physico-chemical and biological compatibility, novel formulation combinations, process scale up, manufacturing and packaging of their drug compounds. |
Organisationstyp | Industry     Größe: 11-50 |
Möchten Sie mit dieser Firma in Kontakt treten? Ja |
|
